Use of complementary and alternative medicine in the management of sickle cell disease
Complementary and alternative medicine in sickle cell
DOI:
https://doi.org/10.22122/cdj.v11i4.627Keywords:
Complementary and Alternative Medicine, Sickle Cell DiseaseAbstract
BACKGROUND: Sickle cell disease (SCD) is the most prevalent genetic hemoglobinopathy with an estimated 300,000 babies born with the disease globally every year. Due to the chronic nature of the disease, there is a pressing need for safe, effective, and affordable therapeutic agents for SCD. In many settings, use of complementary and alternative medicine (CAM) has been reported in the management of the disease. However, there is limited documentation about the use of CAM among patients with SCD in Uganda. Thus, this study was conducted with the aim to determine the prevalence of CAM use and the most commonly used CAM among patients with SCD at Mulago Sickle Cell Clinic (MSCC).
METHODS: This cross-sectional study was conducted for a period of 3 months using an interviewer-administered questionnaire to collect data from 293 participants who were recruited into the study using simple random sampling method at Mulago National Referral Hospital Sickle Cell Clinic, Uganda. The collected data were analyzed using SPSS software to express univariate data as median, mean, mode, percentage, and frequency tables and graphs.
RESULTS: CAM use was reported among 76.7% of the participants with the majority using more than on type of CAM. Biological products were the most commonly used form of CAM followed by spiritual healing; 74.6% of the CAM users used biological products, 25.2% used spiritual healing and prayer, while 0.6% used energy therapies. The most commonly used CAM include avocado leaves (50.9%), herbal concoctions (28.3%), beetroot (19.8%), prayer (18.8%), garlic (13.7%), and anointed water (12.6%).
CONCLUSION: This study found a high prevalence of CAM use among patients with SCD.
References
McGann PT, Hernandez AG, Ware RE. Sickle cell anemia in sub-Saharan Africa: Advancing the clinical paradigm through partnerships and research. Blood. 2017;129(2):155–161.
Wonkam A, Makani J. Sickle cell disease in Africa: an urgent need for longitudinal cohort studies. Lancet Glob Heal. 2019;7(10):e1310–e1311.
Oreagba IA, Oshikoya KA, Amachree M. Herbal medicine use among urban residents in Lagos, Nigeria. BMC Complement Altern Med. 2011;11:1–8.
Nsimba MM, Yamamoto C, Lami JN, Hayakawa Y, Kaji T. Effect of a Congolese herbal medicine used in sickle cell anemia on the expression of plasminogen activators in human coronary aortic endothelial cells culture. J Ethnopharmacol. 2013;146(2):594–599.
Busari AA, Mufutau MA. High prevalence of complementary and alternative medicine use among patients with sickle cell disease in a tertiary hospital in Lagos, South West, Nigeria. BMC Complement Altern Med. 2017;17(1):1–8.
Ndeezi G, Kiyaga C, Hernandez AG, Munube D, Howard TA, Ssewanyana I, et al. Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): A cross-sectional study. Lancet Glob Heal. 2016;4(3):e195–e200.
MOH. World Sickle Cell Day - Ministry of Health- Government of Uganda Report 2019. 2019. https://www.health.go.ug/2019/12/02/world-sickle-cell-day/.
Abere TA, Okoye CJ, Agoreyo FO, Eze GI, Jesuorobo RI, Egharevba CO, et al. Antisickling and toxicological evaluation of the leaves of Scoparia dulcis Linn (Scrophulariaceae). BMC Complement Altern Med. 2015;15(1):1–7.
Tshilolo L, Tomlinson G, Santos B, Olupot-Olupot P, Aygun B, Stuber S. Hydroxyurea for children with sickle cell anemia: Prescribe it early and often. Pediatr Blood Cancer. 2019;66(8). doi:10.1002/pbc.27778.
Oniyangi O, Cohall DH. Phytomedicines (medicines derived from plants) for sickle cell disease. [Review][Update of Cochrane Database Syst Rev. 2010;(10):CD004448; PMID: 20927735]. Cochrane Database Syst Rev. 2013;1:CD004448(4):CD004448, 2013-.
Opoka RO, Ndugwa CM, Latham TS, Lane A, Hume HA, Kasirye P, et al. Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia. Blood J. 2017;130(24):2585–2593.
Birdee GS, Phillips RS, Davis RB, Gardiner P. Factors Associated With Pediatric Use of Complementary and Alternative Medicine. Pediatrics. 2010;125(2):249–256.
Okoronkwo I, Onyia-pat J, Okpala P, Agbo M-A, Ndu A. Patterns of Complementary and Alternative Medicine Use, Perceived Benefits, and Adverse Effects among Adult Users in Enugu Urban, Southeast Nigeria. Evidence-Based Complement Altern Med. 2014;2014:1–6.
Oshikoya K, Senbanjo IO, Njokanma OF, Soipe A. Use of complementary and alternative medicines for children with chronic health conditions in Lagos, Nigeria. BMC Complement Altern Med. 2008;8:1–8.
Sanchez HC, Karlson CW, Hsu JH, Ostrenga A, Gordon C. Complementary and Alternative Medicine Use in Pediatric Hematology/Oncology Patients at the University of Mississippi Medical Center. J Altern Complement Med. 2015;21(11):660–666.
Post-White J, Fitzgerald M, Hageness S, Sencer SF. Complementary and alternative medicine use in children with cancer and general and specialty pediatrics. J Pediatr Oncol Nurs. 2009;26(1):7–15.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Chronic Diseases Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
